Status:

RECRUITING

Pulsed Field Ablation With Concomitant Radiofrequency Cardioneuroablation in Patients With Paroxysmal Atrial Fibrillation

Lead Sponsor:

St. Joseph's Centre, Poland

Conditions:

Atrial Fibrillation (Paroxysmal)

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Pulsed-field ablation (PFA) is a novel, non-thermal method for the treatment of atrial fibrillation (AF). It uses short, high-voltage electrical pulses to selectively ablate cardiomyocytes. PFA has de...

Eligibility Criteria

Inclusion

  • Age ≥18 years
  • Documented paroxysmal atrial fibrillation (AF) lasting ≥30 seconds on ECG or Holter monitoring
  • Willingness and ability to provide written informed consent
  • Life expectancy \>1 year

Exclusion

  • Persistent AF lasting \>7 days or long-standing AF \>1 year
  • Secondary AF due to electrolyte imbalance, thyroid disease, alcohol abuse, or other non-cardiac causes
  • Left atrial anteroposterior diameter ≥45 mm on transthoracic echocardiography
  • Clinically significant coexisting arrhythmias other than AF
  • Significant valvular heart disease or valve prosthesis
  • Chronic heart failure NYHA class III/IV
  • Previous AF or atrial flutter ablation
  • Prior closure of atrial septal defect or left atrial appendage
  • Atrial myxoma
  • Implanted pacemaker or defibrillator
  • History of pericarditis
  • Congenital heart disease
  • Coagulopathy or bleeding disorders
  • Contraindications to oral anticoagulation
  • Contraindications to CT or MRI
  • Pregnancy or breastfeeding
  • Body Mass Index \>30
  • History of organ transplantation
  • Severe pulmonary disease
  • Estimated Glomerular Filtration Rate \<30 mL/min/1.73 m²
  • Active malignancy
  • Significant infection
  • Life expectancy \<1 year
  • Psychiatric disorders preventing study participation
  • Refusal or inability to provide informed consent

Key Trial Info

Start Date :

May 26 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2026

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT07171463

Start Date

May 26 2025

End Date

September 30 2026

Last Update

September 12 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St. Joseph's Heart Rhythm Center

Rzeszów, Podkarpackie Voivodeship, Poland, 35-623